SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 94 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $33,317,000 | +418.1% | 34,608 | +540.4% | 0.00% | – |
| Q1 2022 | $6,431,000 | -84.5% | 5,404 | -57.6% | 0.00% | – |
| Q4 2021 | $41,578,000 | -13.1% | 12,754 | +19.2% | 0.00% | – |
| Q3 2021 | $47,825,000 | +308.3% | 10,699 | +397.9% | 0.00% | – |
| Q2 2021 | $11,712,000 | -74.6% | 2,149 | -65.1% | 0.00% | – |
| Q1 2021 | $46,039,000 | -53.2% | 6,155 | -32.1% | 0.00% | – |
| Q4 2020 | $98,290,000 | +9.3% | 9,059 | -11.0% | 0.00% | – |
| Q3 2020 | $89,938,000 | +170.0% | 10,174 | +225.6% | 0.00% | – |
| Q2 2020 | $33,312,000 | -47.4% | 3,125 | -70.8% | 0.00% | – |
| Q1 2020 | $63,362,000 | +128.5% | 10,685 | +166.3% | 0.00% | – |
| Q4 2019 | $27,730,000 | -40.5% | 4,013 | -10.6% | 0.00% | – |
| Q3 2019 | $46,606,000 | +79.6% | 4,490 | +60.2% | 0.00% | – |
| Q2 2019 | $25,947,000 | -46.0% | 2,802 | -46.7% | 0.00% | – |
| Q1 2019 | $48,058,000 | +455.0% | 5,258 | +623.2% | 0.00% | – |
| Q3 2018 | $8,659,000 | +16.7% | 727 | 0.0% | 0.00% | – |
| Q2 2018 | $7,423,000 | -80.7% | 727 | -75.5% | 0.00% | – |
| Q1 2018 | $38,460,000 | +48.7% | 2,963 | +11.4% | 0.00% | – |
| Q4 2017 | $25,872,000 | +33.6% | 2,659 | +102.1% | 0.00% | – |
| Q3 2017 | $19,372,000 | -10.1% | 1,316 | -1.7% | 0.00% | – |
| Q2 2017 | $21,545,000 | +1252.5% | 1,339 | +1239.0% | 0.00% | – |
| Q1 2017 | $1,593,000 | +9.2% | 100 | -16.7% | 0.00% | – |
| Q4 2016 | $1,459,000 | -36.6% | 120 | -27.7% | 0.00% | – |
| Q3 2016 | $2,302,000 | – | 166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
| Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
| Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
| Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
| Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
| Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
| EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
| Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
| ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |